Adaptive Biotechnologies (FRA:1HM) Pre-Tax Income : €-197.6 Mil (TTM As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Adaptive Biotechnologies Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Adaptive Biotechnologies's pretax income for the three months ended in Jun. 2024 was €-43.0 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was €-197.6 Mil. Adaptive Biotechnologies's pretax margin was -107.08%.

During the past 7 years, Adaptive Biotechnologies's highest Pretax Margin was -80.65%. The lowest was -148.63%. And the median was -111.40%.

Adaptive Biotechnologies Pre-Tax Income Historical Data

The historical data trend for Adaptive Biotechnologies's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adaptive Biotechnologies Pre-Tax Income Chart

Adaptive Biotechnologies Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-61.75

-120.20

-183.46

-189.15

-206.60

Adaptive Biotechnologies Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Pre-Tax Income	Get a 7-Day Free Trial															-44.13	-47.16	-63.70	-43.73	-42.96

Competitive Comparison of Adaptive Biotechnologies's Pre-Tax Income

For the Biotechnology subindustry, Adaptive Biotechnologies's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adaptive Biotechnologies's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adaptive Biotechnologies's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Adaptive Biotechnologies's Pre-Tax Income falls into.

Adaptive Biotechnologies Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Adaptive Biotechnologies's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-184.873	+	-23.318	+	-12.655	+	14.242	+	0
	=	-206.6

Adaptive Biotechnologies's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-37.265	+	-6.693	+	-2.505	+	3.499	+	0
	=	-43.0

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-197.6 Mil.

Adaptive Biotechnologies (FRA:1HM) Pre-Tax Income Explanation

Adaptive Biotechnologies's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-42.964	/	40.124
	=	-107.08%

During the past 7 years, Adaptive Biotechnologies's highest Pretax Margin was -80.65%. The lowest was -148.63%. And the median was -111.40%.

Adaptive Biotechnologies Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Adaptive Biotechnologies's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Adaptive Biotechnologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adaptive Biotechnologies Corp (FRA:1HM) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

ADPT:USA 1HM:Germany

Address

1165 Eastlake Avenue East, Seattle, WA, USA, 98109

Website

https://www.adaptivebiotech.com

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Adaptive Biotechnologies Headlines

No Headlines